The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 21, 2025

Filed:

Jan. 22, 2024
Applicant:

The Trustees of the University of Pennsylvania, Philadelphia, PA (US);

Inventors:

Mark I. Greene, Penn Valley, PA (US);

Douglas B. Cines, Wynnewood, PA (US);

Zheng Cai, Wynnewood, PA (US);

Zhiqiang Zhu, Philadelphia, PA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 33/577 (2005.12); A61K 38/19 (2005.12); A61K 39/395 (2005.12); C07K 14/52 (2005.12); C07K 16/18 (2005.12); C07K 16/24 (2005.12); G01N 33/53 (2005.12); G01N 33/68 (2005.12); G01N 33/86 (2005.12); A61K 39/00 (2005.12);
U.S. Cl.
CPC ...
G01N 33/6863 (2012.12); A61K 38/195 (2012.12); A61K 39/3955 (2012.12); C07K 14/522 (2012.12); C07K 16/24 (2012.12); G01N 33/86 (2012.12); A61K 2039/505 (2012.12); G01N 2333/522 (2012.12); G01N 2400/40 (2012.12); G01N 2800/222 (2012.12); G01N 2800/50 (2012.12); G01N 2800/52 (2012.12);
Abstract

The present invention provides a mutant protein which has the same amino acid sequence of a wild type PF4 monomer except that (i) at least one amino acid of the wild type PF4 monomer has been deleted, (ii) at least one amino acid of the wild type PF4 monomer has been replaced by another amino acid, or (iii) a combination of such changes has been made. The present invention also provides methods of treating or reducing the likelihood of HIT, treating angiogenesis, treating abnormal cell growth, or affecting coagulation pathologies that lead to thrombus formation, by administering such mutant proteins to a patient.


Find Patent Forward Citations

Loading…